Yin C, Zhong R, Zhang W, Liu L, Chen L, Zhang H
Int J Mol Sci. 2023; 24(15).
PMID: 37569498
PMC: 10418921.
DOI: 10.3390/ijms241512123.
Alsultan A, Walton G, Andrews S, Clarke S
Microbiology (Reading). 2023; 169(3).
PMID: 36947574
PMC: 10191381.
DOI: 10.1099/mic.0.001314.
Donadei C, Angeletti A, Cappuccilli M, Conti M, Conte D, Zappulo F
J Clin Med. 2022; 11(3).
PMID: 35160088
PMC: 8836491.
DOI: 10.3390/jcm11030636.
Ahmad T, Haeusler R
Nat Rev Endocrinol. 2019; 15(12):701-712.
PMID: 31616073
PMC: 6918475.
DOI: 10.1038/s41574-019-0266-7.
Wu N, Nguyen Q, Wan Y, Zhou T, Venter J, Frampton G
Lab Invest. 2017; 97(7):843-853.
PMID: 28581486
PMC: 5901959.
DOI: 10.1038/labinvest.2017.29.
Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats.
Al-Salami H, Butt G, Tucker I, Golocorbin-Kon S, Mikov M
Eur J Drug Metab Pharmacokinet. 2011; 37(2):99-108.
PMID: 21874525
DOI: 10.1007/s13318-011-0060-y.
Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism.
Dawson P, Hubbert M, Rao A
Biochim Biophys Acta. 2010; 1801(9):994-1004.
PMID: 20538072
PMC: 2911127.
DOI: 10.1016/j.bbalip.2010.06.002.
Bile acid transporters.
Dawson P, Lan T, Rao A
J Lipid Res. 2009; 50(12):2340-57.
PMID: 19498215
PMC: 2781307.
DOI: 10.1194/jlr.R900012-JLR200.
Bioavailability and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3alpha,7alpha-dihydroxy-12-oxo-5beta-cholanate, in healthy and diabetic rats.
Mikov M, Boni N, Al-Salami H, Kuhajda K, Kevresan S, Golocorbin-Kon S
Eur J Drug Metab Pharmacokinet. 2007; 32(1):7-12.
PMID: 17479538
DOI: 10.1007/BF03190984.
[QUANTITATIVE DETERMINATION OF SERUM CHOLIC ACID FREED THROUGH ALKALINE HYDROLYSISAFTER THIN LAYER CHROMATOGRAPHY].
Frosch B
Klin Wochenschr. 1965; 43:262-6.
PMID: 14257748
DOI: 10.1007/BF01482247.
BILE ACIDS AND OTHER LIPIDS IN THE GALL-BLADDER BILES OF AFRICANS WITH PRIMARY CANCER OF THE LIVER.
MIRVISH S
Br J Cancer. 1964; 13:478-83.
PMID: 14219539
PMC: 2071094.
DOI: 10.1038/bjc.1964.53.
Bile acid composition and bile volume in butter yellow fed rats in relation to liver cancer.
MIRVISH S, GILLMAN J
Br J Cancer. 1960; 14:346-61.
PMID: 13771248
PMC: 2074224.
DOI: 10.1038/bjc.1960.41.
The lipid composition of serum in patients with liver disease.
Phillips G
J Clin Invest. 1960; 39:1639-50.
PMID: 13735297
PMC: 293404.
DOI: 10.1172/JCI104187.
The serum trihydroxy-dihydroxy bile acid ratio in liver and biliary tract disease.
CAREY Jr J
J Clin Invest. 1958; 37(11):1494-503.
PMID: 13587658
PMC: 1062831.
DOI: 10.1172/JCI103741.
Bile acid content of human serum. II. The binding of cholanic acids by human plasma proteins.
RUDMAN D, KENDALL F
J Clin Invest. 1957; 36(4):538-42.
PMID: 13416382
PMC: 1072675.
DOI: 10.1172/JCI103451.
Sodium-coupled taurocholate transport in the proximal convolution of the rat kidney in vivo and in vitro.
Wilson F, Burckhardt G, Murer H, Rumrich G, Ullrich K
J Clin Invest. 1981; 67(4):1141-50.
PMID: 7204571
PMC: 370675.
DOI: 10.1172/jci110128.
Endogenous bile acid tolerance test for liver function.
van Blankenstein M, Frenkel M, van den Berg J, Ten Kate F
Dig Dis Sci. 1983; 28(2):137-44.
PMID: 6825535
DOI: 10.1007/BF01315143.
Quantitative determination of non-sulfated bile acids in the serum of patients with hepatobiliary diseases by mass fragmentography.
Takikawa H, Beppu T, Seyama Y, Wada T
Gastroenterol Jpn. 1983; 18(3):246-51.
PMID: 6307803
DOI: 10.1007/BF02774967.
Serum bile acids in liver disease.
Neale G, Lewis B, Weaver V, Panveliwalla D
Gut. 1971; 12(2):145-52.
PMID: 5548561
PMC: 1411536.
DOI: 10.1136/gut.12.2.145.
Determination of individual bile acids in biological fluids by thin-layer chromatography and fluorimetry.
Panveliwalla D, Lewis B, Wootton I, TABAQCHALI S
J Clin Pathol. 1970; 23(4):309-14.
PMID: 5430420
PMC: 476749.
DOI: 10.1136/jcp.23.4.309.
